Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT)-Reference-Cited by-同舟云学术

Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT)

Published:2017-07-11 Issue:12 Volume:29 Page:e13148
ISSN:1350-1925
Container-title:Neurogastroenterology & Motility
language:en
Short-container-title:Neurogastroenterol Motil

Author:

Bashashati M.¹²^ORCID,Fichna J.¹³^ORCID,Piscitelli F.⁴,Capasso R.⁵,Izzo A. A.⁶,Sibaev A.⁷,Timmermans J.-P.⁸,Cenac N.⁹¹⁰¹¹,Vergnolle N.⁹¹⁰¹¹,Di Marzo V.⁴,Storr M.¹⁷¹²¹³

Affiliation:

1. Snyder Institute for Chronic Diseases; University of Calgary; Calgary AB Canada

2. Division of Gastroenterology; Department of Internal Medicine; Texas Tech University Health Sciences Center/Paul L. Foster School of Medicine; El Paso TX USA

3. Department of Biochemistry; Faculty of Medicine; Medical University of Lodz; Lodz Poland

4. Endocannabinoid Research Group; Istituto di Chimica Biomolecolare; Consiglio Nazionale delle Ricerche; Pozzuoli Italy

5. Department of Agricultural Sciences; University of Naples Federico II; Portici Italy and Endocannabinoid Research Group; Naples Italy

6. Department of Pharmacy; University of Naples Federico II and Endocannabinoid Research Group; Naples Italy

7. Department of Internal Medicine II; Ludwig-Maximilians-University of Munich; Campus Grosshadern; Munich Germany

8. Laboratory of Cell Biology and Histology; University of Antwerp; Antwerp Belgium

9. Inserm; U1220 Toulouse France

10. Institut de Recherche en Sante Digestive (IRSD); Université de Toulouse; Université Paul Sabatier; Toulouse France

11. Department of Pharmacology and Physiology; University of Calgary; Calgary AB Canada

12. Center of Endoscopy; Starnberg Germany

13. Division of Gastroenterology and Department of Medicine; University of Calgary; Calgary AB Canada

Funder

DFG-Sto-645/7-9

University of Munich

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Gastroenterology,Endocrine and Autonomic Systems,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nmo.13148/fullpdf

Reference35 articles.

1. Cannabinoids and the gut: new developments and emerging concepts;Izzo;Pharmacol Ther,2010

2. Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not “higher”;Nasser;Neurogastro Enterol Motil,2014

3. The endocannabinoid system and gut-brain signalling;Storr;Curr Opin Pharmacol,2007

4. Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents;Akbar;Aliment Pharmacol Ther,2009

5. The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1;Fowler;Br J Pharmacol,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of anandamide in digestive and defensive functions of the gut;Anandamide in Health and Disease;2025

2. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years;Pharmacological Reviews;2023-05-10

3. ^ΒN-Alkanoyl-5-Hydroxytryptamines (C_n-5HTs) in Coffee: A Review;Food Reviews International;2022-04-19

4. Cannabinoid and Cannabinoid-Related Receptors in the Myenteric Plexus of the Porcine Ileum;Animals;2021-01-21

5. The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis;European Journal of Medicinal Chemistry;2020-12